Hybio Pharmaceutical Co., Ltd. (300199.SZ) SHZ

21.33

+0.32(+1.52%)

Updated at September 30 03:04PM

Currency In CNY

Valuation

Market Cap11.19B
Enterprise Value12.6B
P/E Ratio-1,044.99
PEG Ratio-13.35
Price/Sales Ratio21.31
Price/Book Ratio25.74
Enterprise/Revenue22.61
Enterprise/EBITDA189.88

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.02
Operating Margin0

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.03

Income Statement

Revenue590.2M
Revenue/Share1.01
Gross Profit336.96M
EBITDA92.35M
Net Income-173.65M
Diluted EPS-0.2

Balance Sheet

Total Cash373.36M
Total Cash/Share0.43
Total Debt1.51B
Total Debt/Equity2.09
Current Ratio0.48
Book Value Per Share0.85

Price History

52-Week Change60.38
52-Week High31.19
52-Week Low10.5
Moving Average 50 Days24.36
Moving Average 200 Days16.74

Statistics

Average Volume103.54M
Shares Outstanding883.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-5.78
Last Split Factor2:1
Last Split DateApril 14, 2015